AJINOMOTO Transglutaminase logo
  • English
  • Français
  • Deutsch
  • Home
Login
  • What is TG?
  • Regulatory Status
  • Safety
  • Celiac Disease & TG
  • Environmental Impact & Benefits
  • Communication
  • News
  • Contact
Safety

How safety was evaluated?

A standard range of safety studies normally conducted with all commercially used food ingredients was performed with ACTIVA® TG in vitro or by using laboratory animals, as follows. No adverse toxicological results were found.

  • Antibacterial residue test and antifungal activity assay
  • Chromosomal Aberration Test (Cultured Mammalian Cells)
  • Mutagenicity Test (Reverse Mutation Assay in Bacteria)
  • Pathogenicity test (mice)
  • Micronucleus Test (mice)
  • Skin Sensitization Test (guinea pigs)
  • Acute Toxicity Test (rats)
  • Thirteen-week Toxicity Test (rats, the no-effect level of TG in this sub-chronic study was considered to be 5.0% (w/w))
  • Stability Test (the results suggest that TG is not active in the stomach, which is characterized by acidic pH, and that TG is completely degraded by pepsin)
     
sort icon
Is TG safe?
How safety was evaluated?
Is TG allergenic during ingestion?
Does TG cause “celiac disease” (CD)?
Is TG widely used in EU?
Is specific preparation necessary for handling transglutaminase?
  • Imprint
Copyright © 2013 AJINOMOTO FOODS EUROPE SAS - Hamburg Branch.